baber/WOPTO huggingface dataset:
Patent CA-3006720-A1 (CA)
Inventor: MOORE DONALD OWEN
IPC: G01D3/032
Filed: 2018-05-30
Abstract: A method for filtering data derived from a process wherein the data is generated by an input of energy. The method includes these steps: collecting the data from the process to create a parent data set; creating a first window of data; calculating an average of the first window of data; comparing the average of the first window of data to a first threshold value; shifting the first window if the average has not passed the first threshold value; creating a second window of data from the parent data set; calculating an average of the second window of data; comparing the average of the second window of data to the threshold value; shifting the second window if the average of the second window of data has not passed the threshold value; and confirming that the threshold value has been reached if the second window average has passed the threshold value.
Patent CA-3009048-A1 (CA)
Title: Composites for use in stimulation and sand control operations
Inventor: MONROE TERRY D
IPC: E21B43/25
Filed: 2014-09-19
Abstract: A composite for treating a wellbore, wherein the composite comprises a solid particulate and a surface modifying treatment agent at least partially coated onto a solid particulate, the surface modifying treatment agent comprising an anchor and at least one hydrophobic tail attached to the anchor wherein the anchor is attached to the solid particulate.
Patent CA-3011793-A1 (CA)
Inventor: LIMON OFER
IPC: G01M11/02
Filed: 2017-01-23
Abstract: Selon certains modes de réalisation illustratifs, l'invention concerne des appareils, des systèmes et/ou des procédés permettant de déterminer un ou plusieurs paramètres optiques d'un verre de lunettes. Par exemple, un produit peut comprendre un ou plusieurs supports de stockage non transitoires lisibles par ordinateur tangibles comprenant des instructions exécutables par ordinateur conçues, lorsqu'elles sont exécutées par au moins un processeur informatique, pour permettre au(x) processeur(s) informatique(s) de traiter au moins une image capturée d'au moins une réflexion d'un flash sur un verre de lunettes; et déterminer un ou plusieurs paramètres optiques du verre d'après au moins la ou les images capturées.
Patent CA-3012983-A1 (CA)
Inventor: WU HSIEN-CHIA
IPC: F23K5/14
Filed: 2018-08-01
Abstract: The invention discloses a high efficiency combustion control system and a method thereof. A high-efficiency combustion control system includes a gasification unit, a gas remixing zone coupled to the gasification unit, a combustion unit coupled to the gas remixing zone; a first gas detecting unit disposed in the gasification unit; a second gas detecting unit disposed in the remixing gas region; and an air supply unit coupled to the gas remixing zone. The first gas detecting unit and the second gas detecting unit detect the concentration of a specific gas of the first gaseous fuel or the second gaseous fuel respectively. And air is supplied to the liquid fuel or the first gaseous fuel according to the gas concentration, so that the gasification rate is changed, and the calorific value is changed accordingly to obtain the optimal calorific value and the optimal combustion efficiency.
Patent CA-3015034-A1 (CA)
Inventor: KARIMI HAMED
IPC: G06F17/10
Filed: 2017-03-02
Abstract: A method is disclosed for preprocessing a problem involving discrete optimization over a plurality of variables, the method comprising obtaining an indication of a problem involving discrete optimization; converting the problem involving discrete optimization into a problem suitable for a given optimization oracle architecture of an optimization oracle; providing a given number of times M the problem suitable for the given optimization oracle architecture to the optimization oracle; for each providing of the problem, performing a given number K of calls to the optimization oracle; each call generating a given configuration; obtaining a variable selection criterion, the variable selection criterion for determining at least one variable of the plurality of generated configurations that can be fixed; determining at least one variable that matches the variable selection criterion and a corresponding value for each variable; fixing the at least one determined variable at the corresponding value in the problem involving discrete optimization to thereby preprocess the problem to generate at least one subproblem and providing an indication of the at least one generated subproblem and an indication of the at least one fixed variable.
Patent CA-3018062-A1 (CA)
Title: Determining the robustness of discrete fracture network permeability estimates
Inventor: HOEINK TOBIAS
IPC: E21B41/00
Filed: 2017-03-17
Abstract: Examples of techniques for determining robustness of a discrete fracture network (DFN) permeability estimate are disclosed. In one example implementation according to aspects of the present disclosure, a method may include: receiving a DFN of an earth formation of interest, the DFN comprising a plurality of connected fractures; determining a directional equivalent permeability of the plurality of connected fractures of the DFN using a numerical upscaling method; and determining the robustness of the directional equivalent permeability.
Patent CA-3020169-A1 (CA)
Title: Voltage regulation for multi-phase power systems
Inventor: DALEY DANIEL JOSEPH
IPC: G05F1/14
Filed: 2017-04-06
Abstract: A power system can include a first tap changer for a first regulated transformer, where the first tap changer has a plurality of first positions. The power system can also include a second tap changer for a second regulated transformer, where the second tap changer has a plurality of second positions. The power system can further include at least one first instrument transformer coupled to the first regulated transformer. The power system can also include at least one second instrument transformer coupled to the second regulated transformer. The power system can further include a controller coupled to the at least one first instrument transformer and the at least one second instrument transformer, where the controller adjusts the first tap changer to a first adjusted position among the first positions based on the first measurements of the first regulated transformer and the second measurements of the second regulated transformer.
Patent CA-3020423-A1 (CA)
Inventor: SYNNOTT REMY
IPC: F01D9/04
Filed: 2018-10-10
Abstract: A turbine shroud segment has a body having a radially outer surface and a radially inner surface extending axially between a leading edge and a trailing edge and circumferentially between a first and a second lateral edge. A first serpentine channel is disposed axially along the first lateral edge. A second serpentine channel is disposed axially along the second lateral edge. The first and second serpentine channels each define a tortuous path including axially extending passages between a front inlet proximate the leading edge and a rear outlet at the trailing edge of the body.
Patent CA-3022200-A1 (CA)
Title: System and method for visualizing and validating process events
Inventor: BIRCHBAUER JOSEF ALOIS
IPC: G05B23/02
Filed: 2017-05-22
Abstract: The invention relates to a method for visualizing and validating process events in process monitoring systems, having the following features: - a permanently installed sensor system reports states to a process monitoring system, - if predefined limit values are exceeded, the process monitoring system initiates, plans and carries out (TR, AC) local data acquisition using a mobile sensor, - the result of this data acquisition is analysed (PR) and visualized (VI) in the process monitoring system and is integrated (PDE) in the state information relating to the process or the installation.
Patent CA-3022386-A1 (CA)
Title: Test d'activite biologique relative pour un vecteur viral codant pour des isomerohydrolases
Inventor: COUTO LINDA
IPC: C12N15/86
Filed: 2017-04-28
Abstract: L'invention concerne des procédés de dosage de l'activité et/ou de la fonction et/ou de l'activité biologique de protéines isomérohydrolases.
Patent CA-3027014-A1 (CA)
Inventor: KOTSCHY ANDRAS
IPC: C07D487/04
Filed: 2017-06-09
Abstract: Compounds of formula (I) wherein R1, R2, R3, n and W are as defined in the description. Medicaments.
Patent CA-3030329-A1 (CA)
Inventor: ZHANG CHONGMING
IPC: H04W48/10
Filed: 2017-07-14
Abstract: The present application provides a method executed by a user equipment. The method comprises: receiving a first system information (SI) message, the first system information (SI) message comprising type information related to a system information block (SIB) and scheduling information of a second system information (SI) message of the type to which the SIB belongs, and the scheduling information comprising a time point on which the second SI message appears and indication information for indicating whether the second SI message is broadcast; and if the indication information indicates that the second SI message is not broadcast, sending an SI request message, and receiving the required system information block (SIB) according to the scheduling information in the received first SI message. The present application also provides a corresponding user equipment and a base station. By using the present invention, unnecessary overheads are avoided and system resources are saved while the demand of a UE for obtaining information is satisfied.
Patent CA-3030499-A1 (CA)
Title: Self-sealing membrane sleeve assembly
Inventor: GANDOLFO PAUL
IPC: F16L5/02
Filed: 2019-01-17
Abstract: A sealing membrane assembly including a flange having a body with a through passage. A first sealing membrane defines a first flexible panel with a first axial sealed opening extending therethrough. The first axial sealed opening extends at an acute angle. A  second sealing membrane defines a second flexible panel with a second axial sealed opening extending therethrough. The second axial sealed opening extends at an obutse angle. The first and second sealing membranes are secured relative to the flange such that the first and second axial sealed openings crisscross one another and the first and second sealing membranes seal the through passage except through the first and second sealed openings.
Patent CA-3030509-A1 (CA)
Inventor: CAMPBELL DARRELL D
IPC: B64C5/08
Filed: 2013-09-25
Abstract: A method comprises forming a wing tip device of an aircraft. The wing tip device, once formed, comprises a unitized, monolithic leading edge torque box. The forming comprises: forming the unitized, monolithic leading edge torque box of the wing tip device using a pair of rigid soluble mandrels which expand upon heating such that the mandrels compact a skin of the leading edge torque box against an outer mold line (OML) tool surface while simultaneously compacting at least one internal component of the leading edge torque box which is positioned between the pair of mandrels; and removing the mandrels by solubilization. Once the wing tip device is formed, the skin defines a continuous, uninterrupted OML surface. The method further comprises passing an airflow over the OML surface of the unitized, monolithic leading edge torque box of the wing tip device. Systems are also disclosed.
Patent CA-3031355-A1 (CA)
Inventor: YUAN CHONG-SHENG
IPC: G01N33/82
Filed: 2017-07-28
Abstract: The present invention provides methods and compositions, e.g., kits, for assaying a vitamin D moiety in a sample, comprising or using, inter alia, a buffer that is capable of dissociating a vitamin D moiety from its binding protein and/or a buffer of acidic pH, and at least two antibodies, e.g., at least two monoclonal antibodies, that are separately conjugated to particles, e.g., latex particles, wherein at least one of said antibodies (or the first antibody) has a specific binding affinity towards the vitamin D moiety, and at least another said antibody (or the second antibody) has a specific binding affinity towards the complex formed between the first antibody and the vitamin D moiety, if present in said sample. In some embodiments, the optical change due to the agglutination reaction between the antibodies and the vitamin D moiety is measured for determination of the amount of vitamin D content in the samples. Kits and reaction mixtures for assaying a vitamin D moiety in a sample are also provided.
Patent CA-3031457-A1 (CA)
Inventor: TANG-LIU DIANE
IPC: A61K47/50
Filed: 2017-09-30
Abstract: A method for preventing and/or treating fibrosis associated with an eye-related disease or disorder includes administering an effective amount of a multikinase inhibitor to a subject in need thereof. The multikinase inhibitor is nintedanib, lenvatinib, a combination thereof, or a salt thereof. The eye-related disease or disorder is corneal transparency, corneal scar formation, secondary cataract formation, glaucoma filtration surgery, ocular surgical procedures and implants, photorefractive keratectomy, laser in situ keratomileusis, formation and contraction of pre- and epiretinal membranes, proliferative vitreoretinopathy, subretinal fibrosis/scarring, retinal gliosis, or formation of choroidal membranes.
Patent CA-3033902-A1 (CA)
Inventor: YANG XIANG-LEI
IPC: C07K16/40
Filed: 2017-08-14
Abstract: Disclosed herein are methods and compositions for modulating angiogenesis, and reducing tumor progression by regulating phosphorylation, of seryl-tRNA synthase (SerRS), Also disclosed are related compositions and methods for treating diseases such as cancer.
Patent CA-3034541-A1 (CA)
Inventor: EGNER SIEGFRIED
IPC: C02F1/461
Filed: 2017-08-22
Abstract: The invention relates to an installation (10) for separating phosphate from phosphate-containing liquids and obtaining phosphate salts, having one or more reactors (12) which each have two electrodes of opposing polarity and which, between them, span a reaction area, wherein each reactor (12) has an inlet (14) and an outlet (16), in which the outlet (16) is separated into a recirculation (22) and a discharge stream (24) and the recirculation (22) supplies part of the liquid from the outlet (16) of the reactor (12) to the inlet of the same reactor or a different reactor (12); and to a method for this and to a biological wastewater treatment plant and to a method for operating the latter.
Patent CA-3037028-A1 (CA)
Inventor: MALTONI ENRICO
IPC: A47J31/30
Filed: 2019-03-15
Abstract: A dispenser unit (1) operated by a lever (16) for use in espresso machines.  The lever (16) is associated with an electric motor (26) which, as selected by an operator, at least partially relieves the effort required to displace the lever (16) for loading the spring (15) that actuates the coffee dispensing piston (11). The same electric motor (26) acts as a brake during the return movement of the lever (16) that loaded the spring (15) of the dispensing piston (11) of the unit. In case of failed coffee dispensing, the braking motor provides an accident-prevention safety feature by preventing any abrupt return movement of the lever (16).
Patent CA-3038991-A1 (CA)
Title: Systeme de gestion logistique ameliore
Inventor: BULCAO NICK
IPC: G06Q50/30
Filed: 2017-10-16
Abstract: La présente invention concerne des systèmes et des procédés d'exécution d'une gestion logistique. Le système de gestion logistique peut recevoir une demande d'expédition d'un paquet provenant d'un dispositif électronique associé à un utilisateur. La demande peut comprendre un emplacement initial et des informations concernant une ou plusieurs caractéristiques du paquet. En réponse à la réception de la demande, un magasin de données électroniques peut être interrogé pour déterminer un ensemble d'itinéraires possibles pour le paquet. L'ensemble d'itinéraires possibles peut ensuite être validé par confrontation avec un ensemble de règles prédéterminées pour produire un sous-ensemble d'itinéraires. L'un du sous-ensemble d'itinéraires peut alors être choisi.
Patent CA-3043892-A1 (CA)
Title: Treatment of respiratory tract diseases and infections with ascorbic acid compositions
Inventor: COPELAND DAN
IPC: C12Q1/18
Filed: 2017-11-17
Abstract: The application is directed to a method of inhibiting or reducing growth of clinical isolate bacteria comprising contacting the clinical isolate with a composition comprising glutathione, a glutathione derivative, a glutathione conjugate, a pharmaceutically-acceptable salt thereof, or any combination thereof.
Patent CA-3044033-A1 (CA)
Inventor: SANDERS HEATHER
IPC: C12Q1/68
Filed: 2017-11-13
Abstract: The present disclosure provides methods for determining whether a patient exhibiting cystic fibrosis symptoms, or a patient at risk for cystic fibrosis, will benefit from treatment with one or more anti-cystic fibrosis therapeutic agents. These methods are based on detecting hereditary cystic fibrosis related mutations in small-volume dried biological fluid samples that are collected using a volumetric absorptive microsampling device. Kits for use in practicing the methods are also provided.
Patent CA-3044267-A1 (CA)
Inventor: FORSELL PETER
IPC: A61M5/168
Filed: 2009-10-09
Abstract: A female external genitalia stimulation system, in particular clitoris erection stimulation system, comprises a fully implantable drug delivery device for delivering a drug in relation to a erectile tissue to achieve erection thereof. The drug delivery device may comprise a catheter adapted to be implanted in the corpora cavernosa of a clitoris or in close proximity thereto in order to deliver drugs through said catheter. Alternatively, one or more infusion needles may be disposed within and implanted along with one or more housings adjacent the patient's left and right corpora cavernosa. A reservoir and a pump may also be implanted inside the patient's body to supply the infusion needle with infusion liquid. A drive unit also adapted for implantation inside the patient's body is arranged for advancing and retracting the tip end of the infusion needle such that it penetrates the housing at least in two different penetration areas either simultaneously or in immediate time succession, thereby injecting drugs along with the infusion liquid into the patient's body for stimulating erectile tissue, in particular for stimulating clitoris erection.
Patent CA-3045069-A1 (CA)
Title: Terminal apparatus, method, and recording medium
Inventor: UCHIYAMA HIROMASA
IPC: H04W92/18
Filed: 2017-10-26
Abstract: [Problem] To provide a mechanism for enabling a terminal device to more flexibly select a communication path between the terminal device and the base station. [Solution] A terminal device equipped with a processing unit that, on the basis of whether a prescribed condition has been fulfilled, determines on a packet-by-packet basis whether to use a base station or a relay terminal as a transmission destination.
Patent CA-3046981-A1 (CA)
Inventor: SAHA GOBINDA
IPC: B01D71/02
Filed: 2019-06-18
Abstract: Transitional metal oxide-coated mesoporous microstructures, uses therefor, and processes for making same are provided. The transitional metal oxide-coated mesoporous microstructures can be silica based, including MCM-41, MCM-45, MCM-48, SBA-15 and SBA-16. The microstructures can include microspheres. The mesoporous microstructures can be produced using a sol-gel process wherein the crystallization step in the sol-gel process is carried out at a low temperature, where the temperature can be 22°C for example. The metal oxide can be titanium dioxide. The titanium dioxide can include titanium dioxide nanocrystals. The transitional metal oxide-coated mesoporous microstructures can be used in environmental applications, such as nanofiltration of contaminated water to remove pollutants.
Patent CA-3047641-A1 (CA)
Title: Derive de triazole azabicyclo-substitue, sa methode de preparation et son application en medecine
Inventor: LI XIN
IPC: C07D405/14
Filed: 2017-12-27
Abstract: La présente invention concerne un dérivé de triazole abicyclo-substitué, sa méthode de préparation et son application en médecine. En particulier, la présente invention concerne un nouveau dérivé de triazole azabicyclo-substitué représenté par la formule générale (I), sa méthode de préparation, une composition pharmaceutique contenant le dérivé, son utilisation en tant qu'agent thérapeutique, en particulier en tant qu'antagoniste de l'ocytocine, et une utilisation de celui-ci dans la préparation d'un médicament pour le traitement ou la prévention d'une maladie ou d'un trouble, le dérivé étant connu pour ou ayant démontré avoir un effet bénéfique sur la maladie ou le trouble avec l'ocytocine supprimée. La définition de chaque substituant dans la formule générale (I) est la même que celle qui figure dans la spécification.
Patent CA-3049576-A1 (CA)
Inventor: CALABRESE ANDREW
IPC: A01N43/44
Filed: 2018-01-03
Abstract: Compositions including derivatives of spinosyns of the following formulae and methods for the production of derivatives of spinosyns are provided. The spinosyn derivatives described herein include those functionalized on the C-5,6 double bond to provide an aziridine ring system. The method produces spinosyn derivatives that exhibit activity towards insects, arachnids, and nematodes and are useful in the agricultural and animal health markets.
Patent CA-3050184-A1 (CA)
Inventor: DORN JURGEN
IPC: A61M25/09
Filed: 2009-06-10
Abstract: A catheter delivery device for a self-expanding stent including a distal catheter component, a distal sheath disposed over the stent, a proximal catheter shaft defining a tube; a proximal sheath connected to the distal sheath defining a lumen containing the catheter shaft, an open distal end suitable to receive the proximal end of the distal catheter component side-by-side with the distal end of the catheter shaft and; a casing tube surrounding the catheter shaft having a distal end telescopically receiving the proximal end of the distal sheath.
Patent CA-3050403-A1 (CA)
Inventor: MENDES ADAM
IPC: A01G31/00
Filed: 2019-07-23
Abstract: Il est décrit un système de culture hydroponique pour la culture de plantes. Le système de culture hydroponique comprend un réservoir de nutriments pour contenir une solution de nutriments, et une pluralité de récipients de culture. Le système de culture hydroponique comprend en outre un système de distribution de nutriments pour distribuer la solution de nutriments du réservoir de nutriments aux récipients de culture. Le système de distribution de nutriments comprend au moins une pompe à eau, un premier tube de liquide et un deuxième tube de liquide, chacun des tubes de liquide étant relié à un récipient de culture d'eau et en communication fluidique avec celui-ci au niveau d'une première extrémité, ainsi quétant relié à une pompe respective et en communication fluidique avec celle-ci au niveau d'une deuxième extrémité. Le système de culture hydroponique comprend en outre un tube de trop-plein s'étendant entre un premier des récipients de culture et un deuxième des récipients de culture.
Patent CA-3050829-A1 (CA)
Inventor: ANDERSEN PEDER OSCAR
IPC: G09F3/00
Filed: 2018-02-16
Abstract: La présente invention concerne des systèmes d'indicateur de durée-température (TTI) pour surveiller l'exposition en termes de durée et de température d'aliments, de nutraceutiques, de produits pharmaceutiques, de produits chimiques et autres produits. Plus particulièrement, la présente invention concerne un système de bouchon, tel qu'un système de bouchon à vis, comprenant un système de TTI.
Patent CA-3052965-A1 (CA)
Inventor: SCALZO HOWARD
IPC: A61L17/10
Filed: 2018-02-06
Abstract: An implantable medical device and method of making it, including a collection of filaments, including a plurality of first variety filaments made of a first polymeric material and at least one second variety filament, and optionally at least one third variety of filament, wherein the second variety filament is coated or impregnated with a first biomedically useful agent and, if present, the third variety of filament is coated or impregnated with a second biomedically useful agent different from the first biomedically useful agent.